MedPath

陕西君寿堂制药有限公司

Ownership
-
Established
2000-07-05
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

65

NMPA:65

Drug Approvals

复肾宁胶囊

Approval Number
国药准字Z20090405
Approval Date
Mar 27, 2024
NMPA

抗宫炎丸

Approval Number
国药准字Z20090568
Approval Date
Mar 27, 2024
NMPA

骨刺消痛胶囊

Approval Number
国药准字Z20090950
Approval Date
Mar 27, 2024
NMPA

炎立消胶囊

Approval Number
国药准字Z20083227
Approval Date
Dec 5, 2023
NMPA

喘嗽宁胶囊

Approval Number
国药准字Z20080304
Approval Date
Dec 5, 2023
NMPA

解郁安神胶囊

Approval Number
国药准字Z20080321
Approval Date
Dec 5, 2023
NMPA

脑心清胶囊

Approval Number
国药准字Z20080325
Approval Date
Dec 5, 2023
NMPA

Paracetamol,Caffein,Atificial Cow-bezoar and Chlorphenamime Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H61022553
Approval Date
Jul 18, 2022
NMPA

清凉防暑颗粒

Approval Number
国药准字Z20054482
Approval Date
Jul 12, 2022
NMPA

宫炎康颗粒

Approval Number
国药准字Z20054534
Approval Date
Jul 12, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.